INCREASE 202:  An Open-label extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease (INCREASE RIN-PH-202)

IRB Protocol #: 1705018243

Overview: The purpose of this research study is to provide or continue to provide inhaled treprostinil to eligible subjects who participated in the RIN-PH-201 study.  This trial is funded by United Therapeutics.

Contact:

Dr. Irina Sobol
Principle Investigator
Email: irs9009@med.cornell.edu
Phone: (212) 746-2381

Melissa Ricketts, MSHS, CCRC
Research Coordinator
Email: mdr2001@med.cornell.edu
Phone: (212) 746-2698